Abstract: Pharmaceutical compositions for improving at least one symptom resulting from tumor cells, which contains a compound represented by the following general formula (1) or a pharmacologically acceptable salt thereof as an active ingredient. wherein R1 represents a hydrogen atom or a C2-4 alkanoyl group and R2 represents a group represented by the following formulae (A), (B), (C), (D), (E), (F) or (G): wherein R3 represents a C1-4 alkyl group.

Abstract: A method of placing concrete into a steel encasement constructing an offshore structure. The steel encasement is erected. A plurality of first concrete injection holes are formed through the steel encasement in a heightwise spaced manner. The concrete is injected through the lowest disposed concrete injection hole into the erected steel encasement to a level below another concrete injection hole disposed just above said lowest disposed concrete injection hole. Then, the injection step is repeated in connection with a subsequent first concrete injection hole nearest to the level, to which the concrete has been placed, for placing the concrete into the steel encasement to a predetermined level.

Abstract: A flowing concrete and a process of producing the same. A cement, water, aggregates, a superplasticizer and a segregation-controlling agent are kneaded into a base concrete having a water-cement ratio of about 35% or less, the segregation-controlling agent contained in an amount of about 0.02 to about 0.1 wt. %, based on the water and including a methylcellulose compound, and the superplasticizer contained in an amount of about 0.25 to about 0.6 wt. % based on the cement. Then, about 0.25 to about 0.6 wt. %, in terms of the solid, of a flowing agent based on the cement is added to the base concrete, the flowing agent including a sulfonic acid/formaldehyde high condensate and a polyvinyl alcohol. Further, the base concrete with the flowing agent is kneaded into the flowing concrete.